Found: 45
Select item for more details and to access through your institution.
Clinical characteristics and outcomes among 2347 patients aged ≥85 years with major lymphoma subtypes: a Nordic Lymphoma Group study.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 551, doi. 10.1111/bjh.17250
- By:
- Publication type:
- Article
A biclonal case of chronic lymphocytic leukaemia with discordant mutational status of the immunoglobulin heavy chain variable region and bimodal CD49d expression.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. e77, doi. 10.1111/bjh.17257
- By:
- Publication type:
- Article
Treating Rosai–Dorfman disease and RAS‐associated autoimmune leucoproliferative disorder with malignant transformation.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 667, doi. 10.1111/bjh.17258
- By:
- Publication type:
- Article
The addition of bendamustine to brentuximab vedotin leads to improved rates of complete metabolic remission in children, adolescents and young adults with relapsed and refractory classical Hodgkin lymphoma: a retrospective single‐centre series.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. e84, doi. 10.1111/bjh.17274
- By:
- Publication type:
- Article
Abnormal eosinophil count at CLL diagnosis correlates with shorter treatment free survival.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. e81, doi. 10.1111/bjh.17264
- By:
- Publication type:
- Article
Strange blood — The Rise and Fall of Lamb Blood Transfusion in 19th Century Medicine and Beyond.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 664, doi. 10.1111/bjh.17287
- By:
- Publication type:
- Article
Ruxolitinib reverses checkpoint inhibition by reducing programmed cell death ligand‐1 (PD‐L1) expression and increases anti‐tumour effects of T cells in multiple myeloma.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 568, doi. 10.1111/bjh.17282
- By:
- Publication type:
- Article
Outcome of relapsed and refractory nodular lymphocyte‐predominant Hodgkin lymphoma: a North American analysis.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 560, doi. 10.1111/bjh.17281
- By:
- Publication type:
- Article
The NICE COVID‐19 rapid guideline on haematopoietic stem cell transplantation: development, implementation and impact.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 467, doi. 10.1111/bjh.17280
- By:
- Publication type:
- Article
BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant for chemosensitive relapses in patients with follicular lymphoma: a prospective multicentre phase II study in Lymphoma Study Association centres<sup>†</sup>
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. e94, doi. 10.1111/bjh.17279
- By:
- Publication type:
- Article
DECC (dexamethasone, etoposide, chlorambucil, lomustine) as an oral chemotherapy regimen in relapsed and refractory diffuse large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. e92, doi. 10.1111/bjh.17278
- By:
- Publication type:
- Article
Janus kinase 2 (JAK2) inhibitors in the treatment of multiple myeloma: modulating the myeloma immune microenvironment.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 420, doi. 10.1111/bjh.17277
- By:
- Publication type:
- Article
Parasitised red blood cells misclassified as giant platelets by an automated digital morphology analyser (Sysmex DI‐60/CellaVision): a case report and a retrospective EQA analysis.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. e90, doi. 10.1111/bjh.17276
- By:
- Publication type:
- Article
Secondary haemophagocytic lymphohistiocytosis is a rare occurrence amongst cancer patients with COVID‐19.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. e87, doi. 10.1111/bjh.17275
- By:
- Publication type:
- Article
IgG subclasses as biomarkers for persistence of factor VIII inhibitors in previously untreated patients with severe haemophilia A.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 621, doi. 10.1111/bjh.17249
- By:
- Publication type:
- Article
Debate: Should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID‐19 while we are awaiting the results of clinical trials?
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 459, doi. 10.1111/bjh.17241
- By:
- Publication type:
- Article
Paediatric severe aplastic anaemia treatment: where to start?
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 417, doi. 10.1111/bjh.17233
- By:
- Publication type:
- Article
Eltrombopag added to immunosuppression for children with treatment‐naïve severe aplastic anaemia.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 605, doi. 10.1111/bjh.17232
- By:
- Publication type:
- Article
Medical therapy to attenuate fetal anaemia in severe maternal red cell alloimmunisation.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 425, doi. 10.1111/bjh.17041
- By:
- Publication type:
- Article
DT‐PACE/ESHAP chemotherapy regimens as salvage therapy for multiple myeloma prior to autologous stem cell transplantation.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. e73, doi. 10.1111/bjh.17248
- By:
- Publication type:
- Article
Comparative analysis of gene expression platforms for cell‐of‐origin classification of diffuse large B‐cell lymphoma shows high concordance.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 599, doi. 10.1111/bjh.17246
- By:
- Publication type:
- Article
Cell‐derived microparticles and sickle cell disease chronic vasculopathy in sub‐Saharan Africa: A multinational study.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 634, doi. 10.1111/bjh.17242
- By:
- Publication type:
- Article
Long‐term complications in uniformly treated paediatric Langerhans histiocytosis patients disclosed by 12 years of follow‐up of the JLSG‐96/02 studies.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 615, doi. 10.1111/bjh.17243
- By:
- Publication type:
- Article
Partial response or better at six months is prognostic of superior progression‐free survival in Waldenström macroglobulinaemia patients treated with ibrutinib.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 542, doi. 10.1111/bjh.17225
- By:
- Publication type:
- Article
The expression levels of long non‐coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 589, doi. 10.1111/bjh.17231
- By:
- Publication type:
- Article
Shotgun sequencing of the faecal microbiome to predict response to steroids in patients with lower gastrointestinal acute graft‐versus‐host disease: An exploratory analysis.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. e69, doi. 10.1111/bjh.17238
- By:
- Publication type:
- Article
Sex differences in outcomes in multiple myeloma.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. e66, doi. 10.1111/bjh.17237
- By:
- Publication type:
- Article
Adult‐onset acute myeloid leukaemia in a patient with germline mutation of CBL.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 665, doi. 10.1111/bjh.17234
- By:
- Publication type:
- Article
Anaplastic large cell lymphoma in human immunodeficiency virus‐infected people and solid organ transplant recipients.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 514, doi. 10.1111/bjh.16778
- By:
- Publication type:
- Article
FANCD2 and HES1 suppress inflammation‐induced PPARɣ to prevent haematopoietic stem cell exhaustion.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 652, doi. 10.1111/bjh.17230
- By:
- Publication type:
- Article
Partial responses to ibrutinib in Waldenström macroglobulinaemia ‐ good enough?
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 423, doi. 10.1111/bjh.17228
- By:
- Publication type:
- Article
A complication risk score to evaluate clinical severity of thalassaemia syndromes.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 626, doi. 10.1111/bjh.17203
- By:
- Publication type:
- Article
UK Guidelines on the Diagnosis and Treatment of Breast Implant‐Associated Anaplastic Large Cell Lymphoma on behalf of the Medicines and Healthcare products Regulatory Agency Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 444, doi. 10.1111/bjh.17194
- By:
- Publication type:
- Article
ABO haemolytic disease of the fetus and newborn in a blood group AB neonate due to maternal immunoglobulin G anti‐A and anti‐B antibodies.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 416, doi. 10.1111/bjh.17133
- By:
- Publication type:
- Article
Investigating the response of paediatric leukaemia‐propagating cells to BCL‐2 inhibitors.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 577, doi. 10.1111/bjh.16773
- By:
- Publication type:
- Article
SARS‐CoV‐2‐induced remission of Hodgkin lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 415, doi. 10.1111/bjh.17116
- By:
- Publication type:
- Article
T cell gene therapy to treat immunodeficiency.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 433, doi. 10.1111/bjh.17070
- By:
- Publication type:
- Article
Disordered serum erythroferrone and hepcidin levels as indicators of the spontaneous abortion occurrence during early pregnancy in humans.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 643, doi. 10.1111/bjh.17049
- By:
- Publication type:
- Article
Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105).
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 531, doi. 10.1111/bjh.16878
- By:
- Publication type:
- Article
FDG‐PET/CT after two cycles of R‐CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome – final result of a UK National Cancer Research Institute prospective study.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 504, doi. 10.1111/bjh.16875
- By:
- Publication type:
- Article
Low‐density lipoprotein receptor (LDLR) is an independent adverse prognostic factor in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 494, doi. 10.1111/bjh.16853
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 409, doi. 10.1111/bjh.16823
- Publication type:
- Article
Clinical outcomes in T‐cell large granular lymphocytic leukaemia: prognostic factors and treatment response.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 484, doi. 10.1111/bjh.16808
- By:
- Publication type:
- Article
Prognostic scoring systems and comorbidities in chronic myelomonocytic leukaemia: a nationwide population‐based study.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 474, doi. 10.1111/bjh.16790
- By:
- Publication type:
- Article
Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1‐acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 522, doi. 10.1111/bjh.16788
- By:
- Publication type:
- Article